Elevated reactive oxygen species (ROS) production and ROS-dependent protein damage is a common observation in the pathogenesis of many muscle wasting disorders, including sarcopenia. However, the contribution of elevated ROS levels to –a breakdown in neuromuscular communication and muscle atrophy remains unknown. In this study, we examined a copper zinc superoxide dismutase [CuZnSOD (Sod1)] knockout mouse (Sod1？/？), a mouse model of elevated oxidative stress that exhibits accelerated loss of muscle mass, which recapitulates many phenotypes of sarcopenia as early as 5 months of age. We found that young adult Sod1？/？ mice display a considerable reduction in hind limb skeletal muscle mass and strength when compared to age-matched wild-type mice. These changes are accompanied by gross alterations in neuromuscular junction (NMJ) morphology, including reduced occupancy of the motor endplates by axons, terminal sprouting and axon thinning and irregular swelling. Surprisingly however, the average density of acetylcholine receptors in endplates is preserved. Using in vivo electromyography and ex vivo electrophysiological studies of hind limb muscles in Sod1？/？ mice, we found that motor axons innervating the extensor digitorum longus (EDL) and gastrocnemius muscles release fewer synaptic vesicles upon nerve stimulation. Recordings from individually identified EDL NMJs show that reductions in neurotransmitter release are apparent in the Sod1？/？ mice even when endplates are close to fully innervated. However, electrophysiological properties, such as input resistance, resting membrane potential and spontaneous neurotransmitter release kinetics (but not frequency) are similar between EDL muscles of Sod1？/？ and wild-type mice. Administration of the potassium channel blocker 3,4-diaminopyridine, which broadens the presynaptic action potential, improves both neurotransmitter release and muscle strength. Together, these results suggest that ROS-associated motor nerve terminal dysfunction is a contributor to the observed muscle changes in Sod1？/？ mice.
References
[1]
Chiarugi P, Fiaschi T, Taddei ML, Talini D, Giannoni E, et al. (2001) Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. J Biol Chem 276: 33478–33487. doi: 10.1074/jbc.m102302200
[2]
Kassmann M, Hansel A, Leipold E, Birkenbeil J, Lu SQ, et al. (2008) Oxidation of multiple methionine residues impairs rapid sodium channel inactivation. Pflugers Arch 456: 1085–1095. doi: 10.1007/s00424-008-0477-6
[3]
Macpherson LJ, Dubin AE, Evans MJ, Marr F, Schultz PG, et al. (2007) Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines. Nature 445: 541–545. doi: 10.1038/nature05544
[4]
Sasaki T, Unno K, Tahara S, Shimada A, Chiba Y, et al. (2008) Age-related increase of superoxide generation in the brains of mammals and birds. Aging Cell 7: 459–469. doi: 10.1111/j.1474-9726.2008.00394.x
[5]
Naumenko N, Pollari E, Kurronen A, Giniatullina R, Shakirzyanova A, et al. (2011) Gender-specific mechanism of synaptic impairment and its prevention by GCSF in a mouse model of ALS. Front Cell Neurosci 5: 26. doi: 10.3389/fncel.2011.00026
[6]
Muller FL, Song W, Liu Y, Chaudhuri A, Pieke-Dahl S, et al. (2006) Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radical Biology and Medicine 40: 1993–2004. doi: 10.1016/j.freeradbiomed.2006.01.036
[7]
Larkin LM, Davis CS, Sims-Robinson C, Kostrominova TY, Remmen HV, et al. (2011) Skeletal muscle weakness due to deficiency of CuZn-superoxide dismutase is associated with loss of functional innervation. Am J Physiol Regul Integr Comp Physiol 301: R1400–7. doi: 10.1152/ajpregu.00093.2011
[8]
Jang YC, Lustgarten MS, Liu Y, Muller FL, Bhattacharya A, et al. (2010) Increased superoxide in vivo accelerates age-associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration. FASEB J 24: 1376–1390. doi: 10.1096/fj.09-146308
[9]
McClung JM, Judge AR, Talbert EE, Powers SK (2009) Calpain-1 is required for hydrogen peroxide-induced myotube atrophy. Am J Physiol Cell Physiol 296: C363–71. doi: 10.1152/ajpcell.00497.2008
[10]
Li YP, Chen Y, Li AS, Reid MB (2003) Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am J Physiol Cell Physiol 285: C806–12. doi: 10.1152/ajpcell.00129.2003
[11]
Alekseenko AV, Waseem TV, Fedorovich SV (2008) Ferritin, a protein containing iron nanoparticles, induces reactive oxygen species formation and inhibits glutamate uptake in rat brain synaptosomes. Brain Res 1241: 193–200. doi: 10.1016/j.brainres.2008.09.012
[12]
Tsentsevitsky A, Nikolsky E, Giniatullin R, Bukharaeva E (2011) Opposite modulation of time course of quantal release in two parts of the same synapse by reactive oxygen species. Neuroscience 189: 93–99. doi: 10.1016/j.neuroscience.2011.05.033
[13]
Borodic GE, Ferrante R, Pearce LB, Smith K (1994) Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord 9: 31–39. doi: 10.1002/mds.870090106
[14]
Spector SA (1985) Trophic effects on the contractile and histochemical properties of rat soleus muscle. J Neurosci 5: 2189–2196.
[15]
Elchuri S, Oberley TD, Qi W, Eisenstein RS, Jackson Roberts L, et al. (2005) CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 24: 367–380. doi: 10.1038/sj.onc.1208207
[16]
Crawley JN (1999) Behavioral phenotyping of transgenic and knockout mice: Experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res 835: 18–26. doi: 10.1016/s0006-8993(98)01258-x
[17]
Urbano FJ, Lino NG, Gonzalez-Inchauspe CM, Gonzalez LE, Colettis N, et al. (2014) Acid-sensing ion channels 1a (ASIC1a) inhibit neuromuscular transmission in female mice. Am J Physiol Cell Physiol 306: C396–406. doi: 10.1152/ajpcell.00301.2013
[18]
Oh SS, Hayes JM, Sims-Robinson C, Sullivan KA, Feldman EL (2010) The effects of anesthesia on measures of nerve conduction velocity in male C57Bl6/J mice. Neurosci Lett 483: 127–131. doi: 10.1016/j.neulet.2010.07.076
[19]
Kaja S, van de Ven RC, van Dijk JG, Verschuuren JJ, Arahata K, et al. (2007) Severely impaired neuromuscular synaptic transmission causes muscle weakness in the Cacna1a-mutant mouse rolling nagoya. Eur J Neurosci 25: 2009–2020. doi: 10.1111/j.1460-9568.2007.05438.x
[20]
McLachlan EM, Martin AR (1981) Non-linear summation of end-plate potentials in the frog and mouse. J Physiol 311: 307–324.
[21]
Jang YC, Liu Y, Hayworth CR, Bhattacharya A, Lustgarten MS, et al. (2012) Dietary restriction attenuates age-associated muscle atrophy by lowering oxidative stress in mice even in complete absence of CuZnSOD. Aging Cell 11: 770–782. doi: 10.1111/j.1474-9726.2012.00843.x
[22]
Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Methods 9: 671–675. doi: 10.1038/nmeth.2089
[23]
Buck M, Chojkier M (1996) Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J 15: 1753–1765.
[24]
Fulle S, Protasi F, Di Tano G, Pietrangelo T, Beltramin A, et al. (2004) The contribution of reactive oxygen species to sarcopenia and muscle ageing. Exp Gerontol 39: 17–24. doi: 10.1016/j.exger.2003.09.012
[25]
Mansouri A, Muller FL, Liu Y, Ng R, Faulkner J, et al. (2006) Alterations in mitochondrial function, hydrogen peroxide release and oxidative damage in mouse hind-limb skeletal muscle during aging. Mech Ageing Dev 127: 298–306. doi: 10.1016/j.mad.2005.11.004
[26]
Vasilaki A, van der Meulen JH, Larkin L, Harrison DC, Pearson T, et al. (2010) The age-related failure of adaptive responses to contractile activity in skeletal muscle is mimicked in young mice by deletion of cu,zn superoxide dismutase. Aging Cell 9: 979–990. doi: 10.1111/j.1474-9726.2010.00635.x
[27]
Flood DG, Reaume AG, Gruner JA, Hoffman EK, Hirsch JD, et al. (1999) Hindlimb motor neurons require cu/zn superoxide dismutase for maintenance of neuromuscular junctions. Am J Pathol 155: 663–72. doi: 10.1016/s0002-9440(10)65162-0
[28]
Fischer LR, Igoudjil A, Magrane J, Li Y, Hansen JM, et al. (2011) SOD1 targeted to the mitochondrial intermembrane space prevents motor neuropathy in the Sod1 knockout mouse. Brain 134: 196–209. doi: 10.1093/brain/awq314
[29]
Sakellariou GK, Davis CS, Shi Y, Ivannikov MV, Zhang Y, et al. (2014) Neuron-specific expression of CuZnSOD prevents the loss of muscle mass and function that occurs in homozygous CuZnSOD-knockout mice. FASEB J 28: 1666–1681. doi: 10.1096/fj.13-240390
[30]
Valdez G, Tapia JC, Kang H, Clemenson GD, Jr, Gage FH, et al. (2010) Attenuation of age-related changes in mouse neuromuscular synapses by caloric restriction and exercise. Proc Natl Acad Sci U S A 107: 14863–14868. doi: 10.1073/pnas.1002220107
[31]
Li Y, Lee Y, Thompson WJ (2011) Changes in aging mouse neuromuscular junctions are explained by degeneration and regeneration of muscle fiber segments at the synapse. J Neurosci 31: 14910–14919. doi: 10.1523/jneurosci.3590-11.2011
[32]
Valdez G, Tapia JC, Lichtman JW, Fox MA, Sanes JR (2012) Shared resistance to aging and ALS in neuromuscular junctions of specific muscles. PLoS One 7: e34640. doi: 10.1371/journal.pone.0034640
[33]
Gould TW, Buss RR, Vinsant S, Prevette D, Sun W, et al. (2006) Complete dissociation of motor neuron death from motor dysfunction by bax deletion in a mouse model of ALS. J Neurosci 26: 8774–8786. doi: 10.1523/jneurosci.2315-06.2006
[34]
Dachs E, Hereu M, Piedrafita L, Casanovas A, Caldero J, et al. (2011) Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy. J Neuropathol Exp Neurol 70: 444–461. doi: 10.1097/nen.0b013e31821cbd8b
[35]
Frey D, Schneider C, Xu L, Borg J, Spooren W, et al. (2000) Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 20: 2534–2542.
[36]
Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, et al. (2004) Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp Neurol 185: 232–240. doi: 10.1016/j.expneurol.2003.10.004
[37]
Kong L, Wang X, Choe DW, Polley M, Burnett BG, et al. (2009) Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J Neurosci 29: 842–851. doi: 10.1523/jneurosci.4434-08.2009
[38]
Murray LM, Comley LH, Thomson D, Parkinson N, Talbot K, et al. (2008) Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum Mol Genet 17: 949–962. doi: 10.1093/hmg/ddm367
[39]
Rozas JL, Gomez-Sanchez L, Tomas-Zapico C, Lucas JJ, Fernandez-Chacon R (2011) Increased neurotransmitter release at the neuromuscular junction in a mouse model of polyglutamine disease. J Neurosci 31: 1106–1113. doi: 10.1523/jneurosci.2011-10.2011
[40]
Kostrominova TY (2010) Advanced age-related denervation and fiber-type grouping in skeletal muscle of SOD1 knockout mice. Free Radical Biology and Medicine 49: 1582–1593. doi: 10.1016/j.freeradbiomed.2010.08.022
[41]
Gordon T, Hegedus J, Tam SL (2004) Adaptive and maladaptive motor axonal sprouting in aging and motoneuron disease. Neurol Res 26: 174–185. doi: 10.1179/016164104225013806
[42]
Zhang Y, Davis C, Sakellariou GK, Shi Y, Kayani AC, et al. (2013) CuZnSOD gene deletion targeted to skeletal muscle leads to loss of contractile force but does not cause muscle atrophy in adult mice. FASEB J 27: 3536–3548. doi: 10.1096/fj.13-228130
[43]
Chen J, Mizushige T, Nishimune H (2012) Active zone density is conserved during synaptic growth but impaired in aged mice. J Comp Neurol 520: 434–452. doi: 10.1002/cne.22764
[44]
Ivannikov MV, Sugimori M, Llinas RR (2013) Synaptic vesicle exocytosis in hippocampal synaptosomes correlates directly with total mitochondrial volume. J Mol Neurosci 49: 223–230. doi: 10.1007/s12031-012-9848-8
[45]
Ly CV, Verstreken P (2006) Mitochondria at the synapse. Neuroscientist 12: 291–299. doi: 10.1177/1073858406287661
[46]
Guo X, Macleod GT, Wellington A, Hu F, Panchumarthi S, et al. (2005) The GTPase dMiro is required for axonal transport of mitochondria to drosophila synapses. Neuron 47: 379–393. doi: 10.1016/j.neuron.2005.06.027
[47]
Giniatullin AR, Darios F, Shakirzyanova A, Davletov B, Giniatullin R (2006) SNAP25 is a pre-synaptic target for the depressant action of reactive oxygen species on transmitter release. J Neurochem 98: 1789–1797. doi: 10.1111/j.1471-4159.2006.03997.x
[48]
Cai SQ, Sesti F (2009) Oxidation of a potassium channel causes progressive sensory function loss during aging. Nat Neurosci 12: 611–617. doi: 10.1038/nn.2291
[49]
Mori S, Kishi M, Kubo S, Akiyoshi T, Yamada S, et al. (2012) 3,4-diaminopyridine improves neuromuscular transmission in a MuSK antibody-induced mouse model of myasthenia gravis. J Neuroimmunol 245: 75–78. doi: 10.1016/j.jneuroim.2012.02.010
[50]
Morsch M, Reddel SW, Ghazanfari N, Toyka KV, Phillips WD (2013) Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody. J Physiol 591: 2747–2762. doi: 10.1113/jphysiol.2013.251827
[51]
Van Lunteren E, Moyer M (1996) Effects of DAP on diaphragm force and fatigue, including fatigue due to neurotransmission failure. J Appl Physiol 81: 2214–2220.
[52]
Duval A, Leoty C (1985) Changes in the ionic currents sensitivity to inhibitors in twitch rat skeletal muscles following denervation. Pflugers Arch 403: 407–414. doi: 10.1007/bf00589254
